AIM
SRTA

ARK Investment Management’s Strata Critical Medical Inc SRTA Stock Holding History

ARK Investment Management’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.4M Sell
2,730,855
-4,724,429
-63% -$24.9M 0.09% 100
2026
Q1 		$31.2M Buy
7,455,284
+344,624
+5% +$1.66M 0.24% 65
2025
Q4 		$34.2M Buy
7,110,660
+706,075
+11% +$3.42M 0.23% 69
2025
Q3 		$32.4M Sell
6,404,585
-2,195,049
-26% -$9.7M 0.19% 70
2025
Q2 		$34.7M Buy
8,599,634
+458,990
+6% +$1.49M 0.25% 59
2025
Q1 		$22.2M Buy
8,140,644
+89,545
+1% +$321K 0.22% 61
2024
Q4 		$34.2M Buy
8,051,099
+833,848
+12% +$3.17M 0.29% 53
2024
Q3 		$21.2M Buy
7,217,251
+774,114
+12% +$2.46M 0.19% 64
2024
Q2 		$22.4M Buy
6,443,137
+230,216
+4% +$768K 0.2% 65
2024
Q1 		$17.7M Sell
6,212,921
-280,864
-4% -$867K 0.12% 85
2023
Q4 		$22.9M Sell
6,493,785
-299,941
-4% -$861K 0.14% 74
2023
Q3 		$17.6M Sell
6,793,726
-168,511
-2% -$592K 0.13% 82
2023
Q2 		$27.4M Buy
6,962,237
+137,713
+2% +$437K 0.18% 68
2023
Q1 		$23.1M Sell
6,824,524
-196,468
-3% -$801K 0.16% 66
2022
Q4 		$25.1M Sell
7,020,992
-318,535
-4% -$1.36M 0.22% 59
2022
Q3 		$29.6M Sell
7,339,527
-514,945
-7% -$2.64M 0.21% 67
2022
Q2 		$54.1M Sell
7,854,472
-521,958
-6% -$3.77M 0.32% 51
2022
Q1 		$71.1M Buy
8,376,430
+434,873
+5% +$3.06M 0.3% 53
2021
Q4 		$70.1M Buy
7,941,557
+2,043,985
+35% +$19.4M 0.21% 69
2021
Q3 		$61.3M Buy
5,897,572
+1,964,340
+50% +$17.2M 0.15% 97
2021
Q2 		$41.3M Buy
+3,933,232
New +$38.8M 0.08% 138

Other funds holding SRTA

TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $366M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

ARK Investment Management's SRTA Position: Q2 2026 in Review

ARK Investment Management reduced its Strata Critical Medical Inc (SRTA) stake by 63% in Q2 2026, selling an estimated $24.9M and leaving 2,730,855 shares worth $14.4M. The position accounts for 0.09% of the portfolio, ranked #100.

ARK Investment Management first reported a position in SRTA in Q2 2021 and has held it in 21 quarters since. The position peaked at $71.1M in Q1 2022. 140 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • ARK Investment Management held 2,730,855 shares of Strata Critical Medical Inc worth $14.4M as of Q2 2026.
  • ARK Investment Management sold 4,724,429 Strata Critical Medical Inc shares in Q2 2026, an estimated $24.9M.
  • Strata Critical Medical Inc made up 0.09% of ARK Investment Management's portfolio in Q2 2026, its #100 holding.
  • ARK Investment Management first reported a position in Strata Critical Medical Inc in Q2 2021 and has held it in 21 quarters since.
  • ARK Investment Management's Strata Critical Medical Inc position peaked at $71.1M in Q1 2022.
  • 140 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on ARK Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.